Compounded Tirzepatide 10mg/1mL – Type 2 Diabetes and Weight Loss Treatment

Overview of Compounded Tirzepatide 

Compounded Tirzepatide 10mg/1mL is an injectable medication prescribed for the treatment of type 2 diabetes and weight loss. It helps regulate blood sugar levels by stimulating insulin secretion. Tirzepatide works by activating both GIP and GLP-1 receptors, which increases insulin production and helps control appetite.

How It Works

Tirzepatide is a GIP/GLP-1 receptor agonist. It triggers insulin secretion in response to glucose intake and reduces food intake by influencing control centers in the brain. This dual-action therapy effectively lowers blood sugar levels and supports sustainable weight loss in individuals with type 2 diabetes.

Dosage and Administration of Compounded Tirzepatide 

• Injection Frequency: Administer once a week at the same time.

• Injection Sites: Choose an injection site on your abdomen, thigh, or upper arm. Rotate sites each week to avoid irritation.

• Needles and Vials: Each order includes a vial of compounded medication and needles for injection under the skin.

Indications

Tirzepatide is approved for adults with type 2 diabetes and is used alongside diet and exercise to improve blood sugar control. It also helps with weight loss in individuals who are overweight (BMI between 27 and 30) or obese (BMI over 30). Tirzepatide is not suitable for type 1 diabetes.

Side Effects of Compounded Tirzepatide 

Common side effects include nausea, vomiting, diarrhea, constipation, indigestion, and abdominal pain. If these side effects persist or worsen, contact your doctor.

Rare but severe side effects include pancreatitis, thyroid tumors, and hypoglycemia, especially when used with other diabetes medications like insulin. Seek medical attention immediately if you experience symptoms such as severe stomach pain or difficulty breathing.

Warnings

• Thyroid Tumors: Tirzepatide may cause thyroid tumors, including cancer, in some individuals. Avoid using it if you have a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia (MEN 2).

• Pancreatitis: If you experience severe abdominal pain that radiates to your back, stop using Tirzepatide and consult a healthcare provider immediately.

• Hypoglycemia: Low blood sugar is possible when Tirzepatide is used with other medications like insulin.

Shipping Information

We ship Compounded Tirzepatide to the following states: Alaska, Florida, Georgia, Idaho, Indiana, Iowa, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Texas, Utah, Virginia, West Virginia. The recipient must be available for delivery.

Consult Your Healthcare Provider

Always follow your healthcare provider’s instructions and monitor your blood sugar levels regularly. Do not stop using Tirzepatide without consulting your doctor. Ensure you have regular check-ups to track your progress.